Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 16Sarcoma 2Genitourinary 2Classical hematology 2Thoracic 1Other neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Anemia 116Neoplasms 77Anemia, Refractory, with Excess of Blasts 32Myelodysplastic Syndromes 31Leukemia, Myeloid, Acute 28Venous Thromboembolism 25Thrombocytopenia 24Leukemia 22Breast Neoplasms 22Febrile Neutropenia 21Neutropenia 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 15Lymphoma 14Hematologic Neoplasms 14Anemia, Sickle Cell 14Ovarian Neoplasms 12Myeloproliferative Disorders 10Leukemia, Lymphocytic, Chronic, B-Cell 10Fanconi Anemia, Complementation Group D1 10Venous Thrombosis 9Primary Myelofibrosis 9Lung Neoplasms 9Leukemia, Myelomonocytic, Chronic 9Prostatic Neoplasms 8Lymphoma, Non-Hodgkin 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Hodgkin Disease 8Pulmonary Embolism 7Hemophilia A 7

Interventions

telapristone acetate 2Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Leiomyoma × Classical hematology × Clear all
NCT00702702 2014-08-21

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
56 enrolled 1 chart
Classical hematology

Anemia, Leiomyoma

NCT00785356 2014-08-21

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
8 enrolled 1 chart
Classical hematology

Anemia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡